COVID-19 vaccines: updates for May 2021

A summary of advice recently issued by the MHRA relating to coronavirus (COVID-19), up to 13 May 2021.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 19 May 2021

• Therapeutic area: Immunology and vaccination

Here we include a summary of key MHRA advice issued up to 13 May 2021 and since the publication of the April 2021 edition of Drug Safety Update.

We continue to publish the summaries of the Yellow Card reporting for the COVID-19 vaccines being used in the UK. The report summarises information received via the Yellow Card scheme and will be published regularly to include other safety investigations carried out by the MHRA under the COVID-19 Vaccine Surveillance Strategy.

We take every report of a suspected adverse reaction seriously and encourage everyone to report through the Coronavirus Yellow Card reporting site.

We have also recently:

• published a statement following the Joint Committee on Vaccination and Immunisation’s new advice on COVID-19 Vaccine AstraZeneca for people aged under 40.

See guidance on COVID-19 for all our latest information, including after publication of this article.

We previously included a summary of latest advice in the January 2021, February 2021, March 2021 and April 2021 issues of Drug Safety Update.

Article citation: Drug Safety Update volume 14, issue 10: May 2021: 2.

Published 19 May 2021